Dr. Deepan Rajamanickam
MS, MCh.
Senior Consultant
- Senior resident in TMH mumbai – 1 Year.
- DM medical oncology course, TMH – 3 Years.
- Junior consultant, Medical oncology TMH – 1 Year.
- Junior consultant, Medical oncology, Global Hospital, Parel, Mumbai for 6 Months.
- Senior Consultant in Thangam Cancer Center since Feb 2017.
M. D. General Medicine, D. M. Medical Oncology
- Multiple lectures and panel based discussions in various national conferences.
- Posters and abstract in international ASH conference.
- Conducting awareness camps and basic talks in oncology for GP s and general public.
- Lomustine, cytarabine, cyclophosphamide, etoposide – An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors Journal of Cancer research and therapeutics, January 2018.
- Paraneoplastic (non-metastatic) adrenal insufficiency preceded the onset of primary lung cancer by 12 weeks Journal of BMJ , January 2009.
- Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer – An Indian exploratory analysis study South Asian J Cancer 2019.
- Ratio of total leukocyte count to C-reactive protein: does it help to differentiate infectious fever from engraftment fever in patients undergoing autologous hematopoietic stem cell transplant? Journal of cellular theraphy and transplantation 2020.
- Multidrug resistant tuberculosis co-existing with aspergilloma and invasive aspergillosis in a 50 year old diabetic woman: a case report 2008.
- Over expression of brain and acute leukemia, cytoplasmic and ETS-related gene is associated with poor outcome in acute myeloid leukemia 2020.
- Treatment pattern post-osimertinib failure in EGFR mutated NSCLC in India-CRSF202002 study 2021.
Practice
Senior resident in TMH mumbai – 1 Year.
DM medical oncology course, TMH – 3 Years.
Junior consultant, Medical oncology TMH – 1 Year.
Junior consultant, Medical oncology, Global Hospital, Parel, Mumbai for 6 Months.
Senior Consultant in Thangam Cancer Center since Feb 2017.
Education & Training
M. D. General Medicine, D. M. Medical Oncology
Affiliations
- Indian Association of Surgical Oncology (IASO)
- Association of Surgeons of India (ASI)
- International Association for the Study of Lung Cancer (IASLC)
- Indian Society of Thoracic Surgery Trusts (ISTST)
- European Society of Thoracic Surgery (ESTS)
- Association of Robotic and Innovative Surgeons (ARIS)
- Society of Robotic Surgery (SRS)
Publications
- Multiple lectures and panel based discussions in various national conferences.
- Posters and abstract in international ASH conference.
- Conducting awareness camps and basic talks in oncology for GP s and general public.
- Lomustine, cytarabine, cyclophosphamide, etoposide – An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors Journal of Cancer research and therapeutics, January 2018.
- Paraneoplastic (non-metastatic) adrenal insufficiency preceded the onset of primary lung cancer by 12 weeks Journal of BMJ , January 2009.
- Practice patterns and outcomes with the use of regorafenib in metastatic colorectal cancer: Results from the Regorafenib in Metastatic colorectal cancer – An Indian exploratory analysis study South Asian J Cancer 2019.
- Ratio of total leukocyte count to C-reactive protein: does it help to differentiate infectious fever from engraftment fever in patients undergoing autologous hematopoietic stem cell transplant? Journal of cellular theraphy and transplantation 2020.
- Multidrug resistant tuberculosis co-existing with aspergilloma and invasive aspergillosis in a 50 year old diabetic woman: a case report 2008.
- Over expression of brain and acute leukemia, cytoplasmic and ETS-related gene is associated with poor outcome in acute myeloid leukemia 2020.
- Treatment pattern post-osimertinib failure in EGFR mutated NSCLC in India-CRSF202002 study 2021.